Skip to main content

AMA Journal of Ethics®

Illuminating the Art of Medicine

Main navigation

  • Home
  • Issues
  • Articles
  • Cases
  • Art
  • Multimedia
  • CME
  • For Authors
  • Call for Papers
  • Editorial Fellows
  • Art Institute of Chicago
  • Conley Winners
  • Trending Topic-Abortion

Search Results

Search

  • (-) History of Medicine (1)
  • CME (1)
  • Health Law (1)
  • Policy Forum (1)
  • (-) Law and medicine/Defensive medicine (1)
  • Reproductive health/Contraception (2)
  • Access to care/Racial, ethnic barriers (1)
  • Chronic disease/Mental health (1)
  • Culturally-conscious care/Appropriate care (1)
  • Degenerative neurological conditions/Persistent vegetative state (1)
  • Ethics/Ethics consultation (1)
  • Ethics/Health policy (1)
  • Health equity/Race and ethnicity (1)
  • Health equity/Structural racism (1)
  • Health professions education/Humanities in health professions education (1)
  • Health professions education/Medical education (1)
  • Interprofessionalism/Scope of practice (1)
  • Justice/Human rights (1)
  • Justice/Resource allocation (1)
  • Patient-clinician relationship/Establishing the relationship, trust (1)
  • Patient safety/Iatrogenic harm (1)
  • Professionalism/Self-regulation (1)
  • Public health/Chronic disease management (1)
  • Trauma/Historical (1)
  • Professionalism (1)
  • Systems-Based Practice (1)
  • Obstetrics and Gynecology (1)
History of Medicine
Sep 2021

FDA Device Oversight From 1906 to the Present

Anna Pisac and Natalia Wilson, MD, MPH
A history of device oversight by the US Food and Drug Administration traces regulatory changes in response to injuries caused by Dalkon Shield intrauterine devices.
AMA J Ethics. 2021;23(9):E712-720. doi: 10.1001/amajethics.2021.712.

AMA Journal of Ethics®

Illuminating the Art of Medicine

Footer menu

  • About
  • Conditions of Use
  • Privacy Policy
  • FAQ
  • Contact
American Medical Association
Copyright 2023 American Medical Association. All Rights Reserved. ISSN 2376-6980